SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 348 filers reported holding SEATTLE GENETICS INC in Q1 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,561,000 | +108.4% | 7,976 | +22.8% | 0.01% | -12.5% |
Q2 2020 | $749,000 | 0.0% | 6,495 | 0.0% | 0.02% | +100.0% |
Q1 2020 | $749,000 | +13.8% | 6,495 | +12.7% | 0.01% | +60.0% |
Q4 2019 | $658,000 | +44.6% | 5,762 | +8.0% | 0.01% | +25.0% |
Q3 2019 | $455,000 | +33.8% | 5,333 | +8.5% | 0.00% | +33.3% |
Q2 2019 | $340,000 | -5.8% | 4,915 | -0.2% | 0.00% | 0.0% |
Q1 2019 | $361,000 | +29.4% | 4,925 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $279,000 | -22.9% | 4,925 | +4.9% | 0.00% | 0.0% |
Q3 2018 | $362,000 | +24.0% | 4,695 | +6.8% | 0.00% | +50.0% |
Q2 2018 | $292,000 | +27.0% | 4,395 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $230,000 | +32.2% | 4,395 | +35.2% | 0.00% | +100.0% |
Q4 2017 | $174,000 | +20.8% | 3,250 | +22.6% | 0.00% | 0.0% |
Q3 2017 | $144,000 | +5.1% | 2,650 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $137,000 | -18.0% | 2,650 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $167,000 | +695.2% | 2,650 | +562.5% | 0.00% | – |
Q4 2016 | $21,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |